SENECI; Pierfausto

Patent Applications and Registrations

Patent applications and USPTO patent grants for SENECI; Pierfausto.The latest application filed is for "aminoguanidine hydrazones as retromer stabilizers useful for treating neurological diseases".

Company Profile

3.15.10

SENECI; Pierfausto - Desenzano del Garda BS IT
Seneci; Pierfausto - Desenzano IT
SENECI; Pierfausto - Desenzano BS IT
Seneci; Pierfausto - Milan IT
Seneci; Pierfausto - Milano IT
Seneci; Pierfausto - Desenzano del Garda N/A IT
Seneci; Pierfausto - Munchen DE
Seneci; Pierfausto -
Seneci; Pierfausto - Brescia IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aminoguanidine Hydrazones As Retromer Stabilizers Useful For Treating Neurological Diseases App 20220213030 - MARTINO; Gianvito ; et al.	2022-07-07
Aza-tanshinone derivatives, process for their preparation and their use in therapy Grant 10,689,342 - Provenzani , et al.	2020-06-23
Aza-tanshinone Derivatives, Process For Their Preparation And Their Use In Therapy App 20190241516 - PROVENZANI; Alessandro ; et al.	2019-08-08
Substituted thiazole or oxazole P2X7 receptor antagonists Grant 10,167,281 - Pevarello , et al. J	2019-01-01
Substituted Thiazole Or Oxazole P2x7 Receptor Antagonists App 20170283409 - Pevarello; Paolo ; et al.	2017-10-05
Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers Grant 9,730,976 - Seneci , et al. August 15, 2	2017-08-15
Substituted thiazole or oxazole P2X7 receptor antagonists Grant 9,718,812 - Pevarello , et al. August 1, 2	2017-08-01
Substituted Thiazole Or Oxazole P2x7 Receptor Antagonists App 20170008883 - Pevarello; Paolo ; et al.	2017-01-12
New Homo- and Heterodimeric SMAC Mimetic Compounds as Apoptosis Inducers App 20160317605 - Seneci; Pierfausto ; et al.	2016-11-03
Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers Grant 9,321,808 - Seneci , et al. April 26, 2	2016-04-26
New Homo- and Heterodimeric SMAC Mimetic Compounds as Apoptosis Inducers App 20150119342 - Seneci; Pierfausto ; et al.	2015-04-30
SMAC mimetic compounds as apoptosis inducers Grant 8,609,685 - Scolastico , et al. December 17, 2	2013-12-17
Smac Mimetic Compounds As Apoptosis Inducers App 20100267692 - Scolastico; Carlo ; et al.	2010-10-21
N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors Grant 7,262,215 - Sahagun-Krause , et al. August 28, 2	2007-08-28
N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors App 20050075386 - Sahagun-Krause, Heidi ; et al.	2005-04-07
Basic proline-amide derivatives of GE 2270 and GE 2270-like antibiotics Grant 6,143,739 - Lociuro , et al. November 7, 2	2000-11-07
Indole derivatives for the treatment of osteoporosis Grant 5,985,905 - Farina , et al. November 16, 1	1999-11-16
Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics Grant 5,891,869 - Lociuro , et al. April 6, 1	1999-04-06
Substituted alkylamide derivatives of teicoplanin Grant 5,500,410 - Malabarba , et al. March 19, 1	1996-03-19
O.sup.56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin Grant 5,185,320 - Trani , et al. February 9, 1	1993-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.